Skip to main content
Have a personal or library account? Click to login
Protection of the vascular endothelium in experimental situations Cover

References

  1. Afanasjev I. (2010). Signaling of reactive oxygen and nitrogen species in Diabetes mellitus.: 361-373.
  2. Babior BM. (1999). NADPH-oxidase. An update.: 1464-1476.
  3. BauerV, Sotníková R and Gergeľ D. (2008). Comparison of the effects of activated neutrophils with the action of reactive oxygen species (ROS) on rat aortic smooth muscle (RASM).: 13-14.
  4. Beckman JS, Beckman TW, Chen J, Marshall PA and Freeman BA. (1990). Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide.: 1620-1324.
  5. Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G and Sessa WC. (2000). In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation.: 1362-1367.
  6. Bucci M, Roviezzo F, Brancaleone V, Lin MI, Di Lorenzo A, Cicala C, Pinto A, Sessa WC, Farneti S, Fiorucci S and Cirino G. (2004). Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression.: 721-726.
  7. Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, Kuoroedov A, Gatti CD, Joch H, Volpe M and Lüscher TF. (2003). High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells.: 1017-1023.
  8. Dai FX, Diederich A, Skopec J and Diederich D. (1993). Diabetes-induced endothelial dysfunction in styreptozotocin-treated rats: role of prostaglandin endoperoxides and free radicals.: 1327-1336.
  9. Garcia-Cardena G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, Lisanti MP and Sessa WC. (1997). Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the NOS caveolin binding domain in vivo.: 25437-25440.
  10. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchov M, Thaiss F, Stahl RAK, Warnholtz A, Meinertz T, Griedling K, Harrison DG, Forstermann U and Munzel T. (2001). Mechanism underlying endothelial dysfunction in diabetes mellitus.: 14-22.
  11. Horáková Ľ and Štolc S. (1998). Antioxidant and pharmacodynamic effects of pyridoindole stobadine.: 627-638.
  12. Karasu C, Ozansoy G, Bozkurt O, Erdoğan D and Omeroğlu S. (1997). Antioxidant and triglyceride-lowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats. Antioxidants in Diabetes-Induced Complications (ADIC) Study Group.: 872-879.
  13. Lukic ML, Ejdus L, Pravica V, Shahin A, Atolic S, Mostarica M, Liew FW, Ramic Z and Badovinac V. (1998). Downregulation of Th-1 mediated autoimmune pathplogy, inpp. 265-278, Academic Press, London/New York.
  14. Májeková M, Šnirc V, Štolc S, Májek P, Bezáková Ž and Sotníková R. (2006). The alpha-adrenolytic and structural evaluation of new pyridoindole derivatives.: 370-378.
  15. Maritim AC, Sanders RA and Watkins JB III. (2003). Diabetes, oxidative stress, and antioxidants: A review.: 24-38.
  16. Moe KT, Aulia S, Jiang F, Chua YL, Koh TH, Wong MC and Dusting GJ. (2006). Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factor-α in human aortic smooth muscle and embryonic kidney cells.: 231-239.
  17. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K and Munzel T. (2002). Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.: 58-65.
  18. Navarová J, Sotníkova R and Knezl V. (1998). Effect of stobadine on lysosomal enzymes in aorta and serum of rats following ischemia and reperfusion.: 158 [in Slovak].
  19. Nosáľová V, Sotníková R, Drábiková K, Fialová S, Košťálová D, Banášová S and Navarová J. (2010). Chemiluminescence response induced by mesenteric ischaemia/reperfusion: effect of antioxidative compounds ex vivo.: 105-108.
  20. Nosáľová V, Navarová J, Mihalová D and Sotniková R. (2007). Mesenteric ischemia/reperfusion-induced intestinal and vascular damage: effect of stobadine.: 39-45.
  21. Nosáľová V, Sotníková R, Mihalová D and Navarová J. (2004). Gut and vessel alterations induced by mesenteric ischemia/reperfusion.: S70-S72.
  22. Okruhlicová Ľ, Weismann P, Sotníková R, Beňuška J, Štefek M, Gajdošik A and Mráz P. (2001). Effect of stobadine and arginine on the structure of diabetic aorta.: 315-316.
  23. Shimokawa H. (1999). Primary endothelial dysfunction: atherosclerosis.: 23-37.
  24. Sotníková R, Bernátová I, Nedelčevová J, Nosáľová V and Navarová J. (2007). Vascular effects of ProvinolsTM in spontaneously hypertensive rats exposed to crowding stress, In, pp. 35-40, Institute of Normal and Pathological Physiology SAS, Bratislava.
  25. Sotníková R, Drábiková K, Beňová M, Nosáľová V, Nosáľ R and Rajská P. (2005). Increased chemiluminiscence accompanies ischaemia/reperfusion-induced endothelial dysfunction of rat superior mesenteric artery.: S145-S147.
  26. Sotniková J, Navarová R, Dytrichová V and Kollárová M. (1997). Biochemical changes in the rat abdominal aorta induced by ischemia - reperfusion, in, p.55, Institute of Experimental Pharmacology SAS, Bratislava.
  27. Sotníková R, Navarová J, Kukan M and Prihelová E. (1999). Endothelial damage of the rat abdominal aorta induced by ischemia/reperfusion: Effect of antioxidants, inBratislava June 27-29, 1999.
  28. Sotníková R, Nosáľová V, Štolc S, Gajdošík A. and Gajdošíková A. (1999a) Streptozotocin diabetes-induced changes in aorta, peripheral nerves and stomach of Wistar rats.: 155-162.
  29. Sotníková R, Okruhlicová Ľ and Noskovič P. (1998). Endothelial protective effect of stobadine on ischaemia-reperfusion-induced injury.: 253-264.
  30. Sotníková R, Okruhlicová Ľ, Dlugošová K, Bernátová I, Bezek Š, Navarová J and Tribulová N. (2008). Effect of n-3 PUFA on endothelium-dependent relaxation of the superior mesenteric artery.(Tribulová N, Okruhlicová Ľ, Slezák J eds) pp.127-134, Institute for Heart Research, Slovak Academy of Sciences and VEDA Publishing House, Bratislava.
  31. Sotníková R, Poništ S, Navarová J, Mihalová D, Tomeková V, Štrosová M and Bauerová K. (2009). Effects of sesame oil in the model of adjuvant arthritis.: S22 - S24.
  32. Sotníková R, Skalská S, Okruhlicová Ľ, Navarová J, Kyseľová Z, Zúrová J, Štefek M, Hozová R and Nosáľová V. (2006a) Changes in the function and ultrastructure of vessels in the rat model of multiple low dose streptozotocininduced diabetes.: 289-302.
  33. Sotníková R, Štefek M, Okruhlicová Ľ, Navarová J, Bauer V, Gajdošík A and Gajdošíková A. (2001). Dietary supplementation of the pyridoindole antioxidant stobadine reduces vascular impairment in streptozotocin-diabetic rats.: 121-129.
  34. Sotníková R, Zúrová J and Bernátová I. (2006). Differences in the response of the mesenteric artery of normotensive and spontaneously hypertensive rast exposed to long-term social stress.(Bernátová I, Kristek F, Pecháňová O, Török J eds) pp 61-69, Comenius University, Bratislava. [in Slovak].
  35. Szöcs K, Žilka N and Sotníková R. (2003). Detection of superoxide and analysis of functional changes in the superior mesenterica artery induced by ischemia and reperfusion., November 12-14, 2003, Senec. pp.36-37 [in Slovak].
  36. Szöcs K. (2004) Endothelial dysfunction and reactive oxygen species. Production in ischemia/reperfusion and nitrate tolerance.: 265-295.
  37. Štolc S, Bauer V, Beneš L and Tichý M. (1983). Czechoslovak Patent. AO-229067
  38. Štolc S, Považanec F, BauerV, Májeková M, Wilcox AL, Šnirc V, Račková L, Sotníková R, Štefek M, Gáspárová-Kvaltínová Z, Gajdošíková A and Mihalová D. (2010). Pyridoindole derivatives with antioxidative properties, their preparation and use in therapeutic practice.PP 287650.
  39. Štolc S, Šnirc V, Májeková M, Gáspárová Z, Gajdošíková A and Štvrtina S. (2006). Development of the new group of indole-derived neuroprotective drugs affecting oxidative stress.: 1495-1504.
  40. Tachi Y, Okuda Y, Bannai C, Bannai S, Shinohara M, Shimpuku H, Yamashita K and Ohura K. (2001). Hyperglycemia in diabetic rats reduces the glutathione content in the aortic tissue.: 1039-1047.
  41. Ujházy E, Dubovický M, Ponechalová V, Navarová J, Brucknerová I, Šnirc V and Mach M. (2008). Prenatal developmental toxicity study of the pyridoindole antioxidant SMe1EC2 in rats.: 639-643.
  42. Urata Y, Yamamoto H, Goto S, Tsushima H, Akazawa S, Yamashita S, Nagataki S and Kondo T. (1996). Long exposure to high glucose concentration impairs the responsive expression of gamma-glutamylcysteine synthetase by interleukin-1 beta and tumor necrosis factor-alpha in mouse endothelial cells.: 15146-15152.
  43. Vanhoutte PM and Mombouli JV. (1996). Vascular endothelium: vasoactive mediators.: 229-238.
  44. Waters PJ, Flyn MD, Corrall RJM and Pennock CA. (1992). Increases in plasma lysosomal enzymes in type 1 (insulin-dependent) diabetes mellitus: relationship to diabetic complications and glycaemic control.: 991-995.
  45. Wendt MC, Daider A, Kleschyov AL, Mülch A, Sydow K, Schulz E, Chen K, Keaney JF, Lassegue B, Walter U, Griendling KK and Münzel T. (2005). Differential effect of diabetes on the expression of the gp91phox homologues nox1 and nox4.: 381-391.
  46. Wigg SJ, Tare M, Tonta MA, O'Brien RC, Meredith IT and Parkington HC. (2001). Comparison pf effects of diabetes mellitus on an EDHF-dependent and an EDHF-independent artery.: H232-H240.
  47. Yan SF, Ramasamy R, Naka Y and Schmidt AM. (2003). Glycation, inflammation, and RAGE. A scaffold for the microvasular complications of diabetes and beynod.: 1159-1169.
  48. Yue KKM, Lee KW, Chan KKC, Leung KSY, Leung AWN and Cheng CHK. (2006). Danshen prevents the occurrence of oxidative stress in the eye and aorta of diabetic rats without affecting the hyperglycemic state.: 136-141.
  49. Zúrová-Nedelčevová J, Navarová J, Drábiková K, Jančinová V, Petriková M, Bernátová I, Kristová V, Šnirc V, Nosáľová V and Sotníková R. (2006). Participation of reactive oxygen species in diabetes-induced endothelial dysfunction.: 68-171.
DOI: https://doi.org/10.2478/v10102-011-0005-y | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 20 - 26
Published on: Apr 18, 2011
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services

© 2011 Ružena Sotníková, Jana Nedelčevová, Jana Navarová, Viera Nosáľová, Katarína Drábiková, Katalin Szöcs, Peter Křenek, Zuzana Kyseľová, Štefan Bezek, Vladimír Knezl, Ján Dřímal, Zuzana Brosková, Viera Kristová, Ľudmila Okruhlicová, Iveta Bernátová, Viktor Bauer, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.